Vplyv blokácie endoglínu na zápalom indukovanú endotelovú dysfunkciu u ľudských aortálnych endotelových buniek

• Název práce v jazyce práce (slovenština): Vplyv blokácie endoglínu na zápalom indukovanú endotelovú dysfunkciu u ľudských aortálnych endotelových buniek
• Název práce v češtině: Vliv blokády endoglinu na zánětem indukovanou endotelovou dysfunkci v lidských aortálních endotelových buňkách
• Název v anglickém jazyce: Effect of endoglin blockage on inflammation-induced endothelial dysfunction in human aortic endothelial cells
• Akademický rok vypsání: 2022/2023
• Typ práce: rigorózní práce
• Jazyk práce: slovenština
• Ústav: Katedra biologických a lékařských věd (16-16150)
• Vedoucí / školitel: PharmDr. Katarína Tripská, Ph.D.
• Řešitel: skrytý - zadáno a potvrzeno stud. odd.
• Datum přihlášení: 13.07.2023
• Datum zadání: 13.07.2023
• Datum potvrzení stud. oddělením: 13.07.2023
• Datum a čas obhajoby: 22.03.2024 00:00
• Datum odevzdání elektronické podoby: 15.03.2024
• Datum proběhlé obhajoby: 22.03.2024
• Oponenti: Mgr. Zuzana Svobodová, Ph.D.

Zásady pro vypracování

Literární rešerše
Praktická experimentální část
Sepsání diplomové práce
Obhajoba diplomové práce

Seznam odborné literatury

1. Bernabeu, C., Lopez-Novoa, J. M., and Quintanilla, M. (2009) The emerging role of TGF-β superfamily coreceptors in cancer. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease1792, 954-973
2. Meurer, S. K., Tihaa, L., Borkham-Kamphorst, E., and Weiskirchen, R. (2011) Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cellular signalling23, 683-699
3. Blázquez-Medela, A. M., García-Ortiz, L., Gómez-Marcos, M. A., Recio-Rodríguez, J. I., Sánchez-Rodríguez, A., López-Novoa, J. M., and Martínez-Salgado, C. (2010) Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients. BMC Med8, 86
4. Bot, P. T., Hoefer, I. E., Sluijter, J. P., van Vliet, P., Smits, A. M., Lebrin, F., Moll, F., de Vries, J. P., Doevendans, P., Piek, J. J., Pasterkamp, G., and Goumans, M. J. (2009) Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke40, 439-447
5. St-Jacques, S., Forte, M., Lye, S. J., and Letarte, M. (1994) Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod51, 405-413
6. Meurer, S., Wimmer, A. E., Leur, E. V., and Weiskirchen, R. (2019) Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation. Cells8
7. Lastres, P., Bellon, T., Cabañas, C., Sanchez-Madrid, F., Acevedo, A., Gougos, A., Letarte, M., and Bernabeu, C. (1992) Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol22, 393-397
8. McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrell, J., and et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet8, 345-351
9. Kapur, N. K., Morine, K. J., and Letarte, M. (2013) Endoglin: a critical mediator of cardiovascular health. Vasc Health Risk Manag9, 195-206
10. Qu, R., Silver, M. M., and Letarte, M. (1998) Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell Tissue Res292, 333-343
11. Alsamman, M., Sterzer, V., Meurer, S. K., Sahin, H., Schaeper, U., Kuscuoglu, D., Strnad, P., Weiskirchen, R., Trautwein, C., and Scholten, D. (2018) Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis. Liver International38, 858-867
12. Vicen, M., Vitverova, B., Havelek, R., Blazickova, K., Machacek, M., Rathouska, J., Najmanová, I., Dolezelova, E., Prasnicka, A., and Sternak, M. (2019) Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro. The FASEB Journal33, 6099-6114
13. Rossi, E., Sanz-Rodriguez, F., Eleno, N., Düwell, A., Blanco, F. J., Langa, C., Botella, L. M., Cabañas, C., Lopez-Novoa, J. M., and Bernabeu, C. (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood121, 403-415
14. Aristorena, M., Gallardo-Vara, E., Vicen, M., de Las Casas-Engel, M., Ojeda-Fernandez, L., Nieto, C., Blanco, F. J., Valbuena-Diez, A. C., Botella, L. M., and Nachtigal, P. (2019) MMP-12, secreted by pro-inflammatory macrophages, targets endoglin in human macrophages and endothelial cells. International journal of molecular sciences20, 3107
15. Hawinkels, L. J., Kuiper, P., Wiercinska, E., Verspaget, H. W., Liu, Z., Pardali, E., Sier, C. F., and ten Dijke, P. (2010) Matrix metalloproteinase-14 (MT1-MMP)–mediated endoglin shedding inhibits tumor angiogenesis. Cancer research70, 4141-4150
16. Valbuena-Diez, A. C., Blanco, F. J., Oujo, B., Langa, C., Gonzalez-Nuñez, M., Llano, E., Pendas, A. M., Díaz, M., Castrillo, A., and Lopez-Novoa, J. M. (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation126, 2612-2624
17. Blaha, M., Cermanova, M., Blaha, V., Jarolim, P., Andrys, C., Blazek, M., Maly, J., Smolej, L., Zajic, J., Masin, V., Zimova, R., and Rehacek, V. (2008) Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis197, 264-270
18. Blann, A. D., Wang, J. M., Wilson, P. B., and Kumar, S. (1996) Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis120, 221-226
19. Malhotra, R., Paskin-Flerlage, S., Zamanian, R. T., Zimmerman, P., Schmidt, J. W., Deng, D. Y., Southwood, M., Spencer, R., Lai, C. S., Parker, W., Channick, R. N., Morrell, N. W., Elliott, C. G., and Yu, P. B. (2013) Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension. Pulm Circ3, 369-380
20. Leaños-Miranda, A., Navarro-Romero, C. S., Sillas-Pardo, L. J., Ramírez-Valenzuela, K. L., Isordia-Salas, I., and Jiménez-Trejo, L. M. (2019) Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes. Hypertension74, 991-997
21. Doghish, A. S., Bassyouni, A. A., Mahfouz, M. H., Abd El-Aziz, H. G., and Zakaria, R. Y. (2019) Plasma endoglin in Type2 diabetic patients with nephropathy. Diabetes Metab Syndr13, 764-768
22. Vitverova, B., Blazickova, K., Najmanova, I., Vicen, M., Hyšpler, R., Dolezelova, E., Nemeckova, I., Tebbens, J. D., Bernabeu, C., Pericacho, M., and Nachtigal, P. (2018) Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta. Atherosclerosis271, 15-25
23. Gallardo-Vara, E., Gamella-Pozuelo, L., Perez-Roque, L., Bartha, J. L., Garcia-Palmero, I., Casal, J. I., López-Novoa, J. M., Pericacho, M., and Bernabeu, C. (2020) Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4. Cells9
24. Finnson, K. W., and Philip, A. (2012) Endoglin in liver fibrosis. J Cell Commun Signal6, 1-4
25. García-Pozo, L., Miquilena-Colina, M. E., Lozano-Rodríguez, T., and García-Monzón, C. (2008) [Endoglin: structure, biological functions, and role in fibrogenesis]. Rev Esp Enferm Dig100, 355-360
26. Ioannou, G. N. (2016) The Role of Cholesterol in the Pathogenesis of NASH. Trends Endocrinol Metab27, 84-95
27. Clemente, M., Nunez, O., Lorente, R., Rincon, D., Matilla, A., Salcedo, M., Catalina, M., Ripoll, C., Iacono, O., and Banares, R. (2006) Increased intrahepatic and circulating levels of endoglin, a TGF‐β1 co‐receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. Journal of viral hepatitis13, 625-632
28. Meurer, S. K., Alsamman, M., Scholten, D., and Weiskirchen, R. (2014) Endoglin in liver fibrogenesis: Bridging basic science and clinical practice. World J Biol Chem5, 180-203
29. Preativatanyou, K., Honsawek, S., Chongsrisawat, V., Vejchapipat, P., Theamboonlers, A., and Poovorawan, Y. (2010) Correlation of circulating endoglin with clinical outcome in biliary atresia. European journal of pediatric surgery20, 237-241
30. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y. C., Torbenson, M. S., and Unalp‐Arida, A. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology41, 1313-1321
31. Hirsova, P., Weng, P., Salim, W., Bronk, S. F., Griffith, T. S., Ibrahim, S. H., and Gores, G. J. (2017) TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity. Hepatology communications1, 648-662
32. Ariz, U., Mato, J. M., Lu, S. C., and Chantar, M. L. M. (2010) Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? In Bioinformatics Methods in Clinical Research pp. 109-136, Springer
33. García-Monzón, C., Martín-Pérez, E., Iacono, O. L., Fernández-Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., and Moreno-Otero, R. (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol33, 716-724
34. Dolezelova, E., Sa, I. C. I., Prasnicka, A., Hroch, M., Hyspler, R., Ticha, A., Lastuvkova, H., Cermanova, J., Pericacho, M., and Visek, J. (2019) High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice. Life sciences232, 116643
35. Charlton, M., Krishnan, A., Viker, K., Sanderson, S., Cazanave, S., McConico, A., Masuoko, H., and Gores, G. (2011) Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. American Journal of Physiology-Gastrointestinal and Liver Physiology301, G825-G834
36. Krishnan, A., Abdullah, T. S., Mounajjed, T., Hartono, S., McConico, A., White, T., LeBrasseur, N., Lanza, I., Nair, S., and Gores, G. (2017) A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. American Journal of Physiology-Gastrointestinal and Liver Physiology312, G666-G680
37. Hirsova, P., Karlasova, G., Dolezelova, E., Cermanova, J., Zagorova, M., Kadova, Z., Hroch, M., Sispera, L., Tomsik, P., and Lenicek, M. (2013) Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology303, 9-15
38. Prasnicka, A., Cermanova, J., Hroch, M., Dolezelova, E., Rozkydalova, L., Smutny, T., Carazo, A., Chladek, J., Lenicek, M., and Nachtigal, P. (2017) Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids1862, 1469-1480
39. Chiappini, F., Desterke, C., Bertrand-Michel, J., Guettier, C., and Le Naour, F. (2016) Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models. Scientific reports6, 31587
40. Gallardo-Vara, E., Blanco, F. J., Roqué, M., Friedman, S. L., Suzuki, T., Botella, L. M., and Bernabeu, C. (2016) Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury. Angiogenesis19, 155-171
41. Miele, L., Beale, G., Patman, G., Nobili, V., Leathart, J., Grieco, A., Abate, M., Friedman, S. L., Narla, G., Bugianesi, E., Day, C. P., and Reeves, H. L. (2008) The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology135, 282-291.e281
42. Hayashi, M., Nomoto, S., Hishida, M., Inokawa, Y., Kanda, M., Okamura, Y., Nishikawa, Y., Tanaka, C., Kobayashi, D., and Yamada, S. (2014) Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC cancer14, 108
43. Zhu, H.-J., and Burgess, A. W. (2001) Regulation of transforming growth factor-β signaling. Molecular cell biology research communications4, 321-330
44. Tobar, N., Avalos, M. C., Méndez, N., Smith, P. C., Bernabeu, C., Quintanilla, M., and Martínez, J. (2014) Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells. Carcinogenesis35, 1770-1779
45. Rath, T., Hage, L., Kügler, M., Menendez Menendez, K., Zachoval, R., Naehrlich, L., Schulz, R., Roderfeld, M., and Roeb, E. (2013) Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One8, e58955
46. Yagmur, E., Rizk, M., Stanzel, S., Hellerbrand, C., Lammert, F., Trautwein, C., Wasmuth, H. E., and Gressner, A. M. (2007) Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. Eur J Gastroenterol Hepatol19, 755-761
47. Vitverova, B., Najmanova, I., Vicen, M., Tripska, K., Sa, I. C. I., Hyspler, R., Pericacho, M., and Nachtigal, P. (2020) Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts. PLoS One15, e0233725
48. Lau, J. K. C., Zhang, X., and Yu, J. (2017) Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances. The Journal of pathology241, 36-44
49. Cohen, J. C., Horton, J. D., and Hobbs, H. H. (2011) Human fatty liver disease: old questions and new insights. Science332, 1519-1523
50. Ipsen, D. H., Lykkesfeldt, J., and Tveden-Nyborg, P. (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci75, 3313-3327
signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut67, 1881-1891